Cargando…

AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report

BACKGROUND: The recently updated European LeukemiaNet risk stratification guidelines combine cytogenetic abnormalities and genetic mutations to provide the means to triage patients with acute myeloid leukemia for optimal therapies. Despite the identification of many prognostic factors, relatively fe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pogosova-Agadjanyan, Era L., Moseley, Anna, Othus, Megan, Appelbaum, Frederick R., Chauncey, Thomas R., Chen, I-Ming L., Erba, Harry P., Godwin, John E., Jenkins, Isaac C., Fang, Min, Huynh, Mike, Kopecky, Kenneth J., List, Alan F., Naru, Jasmine, Radich, Jerald P., Stevens, Emily, Willborg, Brooke E., Willman, Cheryl L., Wood, Brent L., Zhang, Qing, Meshinchi, Soheil, Stirewalt, Derek L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425159/ https://www.ncbi.nlm.nih.gov/pubmed/32817791 http://dx.doi.org/10.1186/s40364-020-00208-1

Ejemplares similares

Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research Network
por: Termini, Christina M., et al.
Publicado: (2023)

Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients
por: Pogosova-Agadjanyan, Era L., et al.
Publicado: (2023)

Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis
por: Zarnegar-Lumley, Sara, et al.
Publicado: (2023)

The Prognostic Significance of IRF8 Transcripts in Adult Patients with Acute Myeloid Leukemia
por: Pogosova-Agadjanyan, Era L., et al.
Publicado: (2013)

Copy-neutral loss of heterozygosity is prevalent and a late event in the pathogenesis of FLT3/ITD AML
por: Stirewalt, D L, et al.
Publicado: (2014)

Gene Expression Patterns in Myelodyplasia Underline the Role of Apoptosis and Differentiation in Disease Initiation and Progression
por: Bar, Merav, et al.
Publicado: (2008)

Improved outcomes with “7+3” induction chemotherapy for acute myeloid leukemia over the past four decades: analysis of SWOG trial data
por: Othus, Megan, et al.
Publicado: (2022)

Relative survival following response to 7+3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes:An analysis of four SWOG studies
por: Othus, Megan, et al.
Publicado: (2018)

Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia
por: Farrar, Jason E., et al.
Publicado: (2023)

Molecular alterations of the IDH1 gene in AML: a Children’s Oncology Group and Southwest Oncology Group study
por: Ho, Phoenix A., et al.
Publicado: (2010)

Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemia
por: Michelson, Andrew P., et al.
Publicado: (2020)

Comparison of Two Methods for Detecting Alternative Splice Variants Using GeneChip(®) Exon Arrays
por: Fan, Wenhong, et al.
Publicado: (2011)

Effect of Measurable (“Minimal”) Residual Disease (MRD) Information on Prediction of Relapse and Survival in Adult Acute Myeloid Leukemia
por: Othus, Megan, et al.
Publicado: (2016)

Mitoxantrone, Etoposide, and Cytarabine (MEC) Following Epigenetic Priming with Decitabine in Adults with Relapsed/Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms: A Phase 1/2 Study
por: Halpern, Anna B., et al.
Publicado: (2017)

Resistance Prediction in AML: Analysis of 4,601 Patients from MRC/NCRI, HOVON/SAKK, SWOG, and MD Anderson Cancer Center
por: Walter, Roland B., et al.
Publicado: (2014)

Pre- and Post-Transplant Quantification of Measurable (“Minimal”) Residual Disease via Multiparameter Flow Cytometry in Adult Acute Myeloid Leukemia
por: Zhou, Yi, et al.
Publicado: (2016)

Prediction of CR following a second course of ‘7+3' in patients with newly diagnosed acute myeloid leukemia not in CR after a first course
por: Othus, M, et al.
Publicado: (2016)

Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512
por: Bhatia, Shailender, et al.
Publicado: (2012)

MicroRNA-150 Expression Induces Myeloid Differentiation of Human Acute Leukemia Cells and Normal Hematopoietic Progenitors
por: Morris, Valerie A., et al.
Publicado: (2013)

Experiences with a researcher-centric ELN
por: Badiola, Katrina A., et al.
Publicado: (2015)

The New ELN Recommendations for Treating CML
por: Hehlmann, Rüdiger
Publicado: (2020)

Transcriptome Profiling of Pediatric Core Binding Factor AML
por: Hsu, Chih-Hao, et al.
Publicado: (2015)

Pre-treatment Amino Acids and Risk of Paclitaxel-induced Peripheral Neuropathy in SWOG S0221
por: Chen, Ciao-Sin, et al.
Publicado: (2023)

Drug-drug interactions in subjects enrolled in SWOG trials of oral chemotherapy
por: Marcath, Lauren A., et al.
Publicado: (2021)

Institutional ELN/LIMS deployment: Highly customizable ELN/LIMS platform as a cornerstone of digital transformation for life sciences research institutes
por: Argento, Nicolas
Publicado: (2020)

Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation
por: Jentzsch, Madlen, et al.
Publicado: (2022)

What is VaxEln really like?: a user's view
por: Burkimsher, Paul C
Publicado: (1985)

Solving the Mystery of Myelodysplasia
por: Radich, Jerald
Publicado: (2008)

Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC
por: Huber, Sandra, et al.
Publicado: (2023)

An evaluation of stakeholder engagement in comparative effectiveness research: lessons learned from SWOG S1415CD
por: Bell-Brown, Ari, et al.
Publicado: (2022)

ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation
por: Jentzsch, Madlen, et al.
Publicado: (2020)

ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol
por: Buccisano, Francesco, et al.
Publicado: (2022)

Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630
por: Potkul, Ronald K, et al.
Publicado: (2016)

Evaluation of the Sensitivity to Endocrine Therapy Index and 21-Gene Breast Recurrence Score in the SWOG S8814 Trial
por: Speers, Corey W., et al.
Publicado: (2023)

Subnuclear physics: the first 50 years, highlights from Erice to ELN
por: Zichichi, A, et al.
Publicado: (2000)

Subnuclear physics: the first fifty years, highlights from Erice to ELN
por: Zichichi, Antonino, et al.
Publicado: (1998)

openBIS ELN-LIMS: an open-source database for academic laboratories
por: Barillari, Caterina, et al.
Publicado: (2016)

Chemotion ELN: an Open Source electronic lab notebook for chemists in academia
por: Tremouilhac, Pierre, et al.
Publicado: (2017)

Emerging Role of Edible Exosomes-Like Nanoparticles (ELNs) as Hepatoprotective Agents
por: Subudhi, P. Debishree, et al.
Publicado: (2022)

ELN missense variant in patient with mid-aortic syndrome case report
por: Phan, Thao Nguyen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d89hh7ganee2stean1ht5eg3hl